Gallo, M.F., Grimmes, D.A., Schulz, K.F. and Helmershorst, F.M. (2004) Combination Estrogen-Progestin Contraceptives and Body Weight: Systematic Review of Randomised Control Trials. Obstetrics & Gynecology, 103, 359-373.
 Fraser, I.S., Jensen, J., Schaefers, M., Mellinger, U., Parke, S. and Serrani, M. (2012) Normalisation of Blood Loss in Women with Heavy Menstrual Bleeding Treated with Oral Containing Estradiol Valerate/Dienogest. Contraception, 86, 96-101.
 Fruzzetti, F., Tremollieres, F. and Bitzer, J. (2012) An Overview of the Development of Combined Oral Contraceptives Containing Estradiol: Focus on Estradiol Valerate/Dienogest. Gynecological Endocrinology, 28, 400-408.
 Iklaki, C.U., Inaku, J.E., Ekabua, J.E., Odusolu, P.O. and Njoku, C.O. (2012) Use of Combined Oral Contraceptive Pill among Teenage Girls in Calabar, Nigeria. Open Access Journal of Contraception, 3, 31-35.
 Michelle, M.D., Roland, T. and Burkman, M.D. (2003) Contraception and Family Planning. In: Decherny, A.H. and Laurent, N., Eds., Current Obstetrics and Gynaecologic Diagnosis and Treatment, Lang Medical Books/McGraw-Hill Companies, Inc., New York, 631-650.
 Mansour, D., Inki, P. and Gemzell-Danielsson, K. (2010) Efficacy of Contraceptive Methods. A Review of the Literature. The European Journal of Contraception and Reproductive Health Care, 15, 4-16.
 Klippin, C., Duijkens, T., Trummer, D. and Marr, J. (2008) Suppression of Ovarian Activity with Drospirenone Containing Oral Contraceptive in a 24/4 Regime. Contraception, 78, 16-25.
 Curtis, K.M., Chrisman, C.E. and Peterson, A.B. (2002) WHO Programme for Mapping Best Practices in Reproductive Health. Contraception for Women in Selected Circumstances. Obstetrics & Gynecology, 99, 1100-1112.
 World Health Organisation (2011) Department of Reproductive Health and Research. Family Planning: A Global Handbook for Providers: Evidence-Based Guidance Developed through Worldwide Collaboration, Geneva Switzerland. WHO centre for Communications Program, 1-10.
 Shulman, L.P. (2011) The State of Hormonal Contraception Today: Benefits and Risks of Hormonal Contraceptives: Combined Estrogen and Progestin Contraceptives. American Journal of Obstetrics & Gynecology, 205, S9-S13.
 Ojule, J.D. and Oranu, E.O. (2017) Birth Control Pills Profile of Acceptors at the University of Port Harcourt Teaching Hospital, Port Harcourt Nigeria. British Journal of Medicine and Medical Research, 20, 1-7.
 Wu, J., Wang, L., Rauyajin, O. and Good, S. (2002) Contraceptive Use Behaviour among Never Married Young Women Who Are Seeking Pregnancy Termination in Beijing. Chinese Medical Journal, 115, 851-855.
 Oye-Adeniran, B.A., Adewole, I.F., Odeyemi, K.A., Ekanem, E.E. and Umoh, A.V. (2005) Contraceptive Prevalence among Young Women in Nigeria. Journal of Obstetrics and Gynaecology, 25, 182-185.
 Datey, S., Gaur, L.N. and Saxena, B.N. (1995) Vaginal Bleeding Patterns of Women Using Different Contraceptive Methods (Implants, Injectables, IUDs, Oral Pills): An Indian Experience. An ICMR Task Force Study. Contraception, 51, 155-165.
 Chigbu, B., Onwere, S., Aluka, C., Kamanu, C., Okoro, O. and Feyi-Waboso, P. (2010) Contraceptive Choices of Women in Rural South-Eastern Nigeria. Nigerian Journal of Clinical Practice, 13, 195-199.
 Rosenberg, M. (1998) Weight Change with Oral Contraceptive Use and during the Menstrual Cycle. Results of Daily Measurements. Contraception, 58, 345-349.
 Ojule, J.D. and Oranu, E.O. (2017) Experience with Combined Injectable Contraceptive (Norigynon) in Port Harcourt. British Journal of Medicine and Medical Research, 19, 1-6.